ELN is a crucial element of the extracellular matrix that promotes breast cancer progression by enhancing the activation of matrix metalloproteinases (MMPs) but is scarcely documented in BLCA [37]. This evidence concerns the gene ELN and bladder transitional cell carcinoma.